Abstract Extracellular Vesicles (EVs) are membranous vesicles produced by all cells under
physiological and pathological conditions. In hematological malignancies, tumor-derived …

Many cell types release extracellular vesicles (EVs), including exosomes, microvesicles
(MVs), and apoptotic bodies, which play a role in physiology and diseases. Presence and …

The recent introduction of the “precision medicine” concept in oncology pushed cancer
research to focus on dynamic measurable biomarkers able to predict responses to novel …

Extracellular vesicles (EVs) represent promising circulating biomarkers for cancers, but their
high‐throughput analyses in clinical settings prove challenging due to lack of simple, fast …

Simple Summary Extracellular vesicles (EVs) are lipid bound vesicles secreted by cells into
the extracellular space. They play an important role in cell-to-cell communication by …

Extracellular vesicles (EVs) have emerged as a valuable source for disease biomarkers and
an alternative drug delivery system due to their ability to carry cargo and target specific cells …

Extracellular vesicles (EVs) are nanoscale vesicles secreted by normal and pathological
cells. The types and levels of surface proteins and internal nucleic acids in EVs are closely …

The tumor microenvironment (TME) plays an important role in the development and
progression of hematological malignancies. In recent years, studies have focused on …

Small extracellular vesicles (EVs) are a heterogenous group of lipid particles released by all
cell types in physiological and pathological states. In hematological malignancies, tumor …

Extracellular vesicles (EVs) have great potential as biomarkers since their composition and
concentration in biofluids are disease state dependent and their cargo can contain disease …